0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Neuroprotection - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-1A4377
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neuroprotection Market Insights and Forecast to 2028
BUY CHAPTERS

Neuroprotection - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-1A4377
Report
November 2023
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neuroprotection - Market Size

The global Neuroprotection market size is expected to reach US$ 32780 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029.

Neuroprotection -  Market

Neuroprotection - Market

Neuroprotection is defined as an involvement able to affect the etiology or the pathogenesis underlying neurodegenerative diseases.
The market is mainly driven by the significant applications of Neuroprotection in various end use industries. The expanding demands from the Prevention and Treatment, are propelling Neuroprotection market. Free Anti-Inflammatory Agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radical Trapping Agents (Antioxidants) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Neuroprotection market, driven by demand from China, the second largest economy with some signs of stabilising, the Neuroprotection market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neuroprotection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Neuroprotection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neuroprotection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neuroprotection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neuroprotection covered in this report include F. Hoffmann-La Roche, Eli Lilly and Company, Daiichi Sankyo Company, Allergan, Novartis, AstraZeneca, Dr. Reddy's Laboratories, Astrocyte Pharmaceuticals and Teva Pharmaceutical Industries, etc.
The global Neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F. Hoffmann-La Roche
Eli Lilly and Company
Daiichi Sankyo Company
Allergan
Novartis
AstraZeneca
Dr. Reddy's Laboratories
Astrocyte Pharmaceuticals
Teva Pharmaceutical Industries
Biogen

Scope of Neuroprotection - Market Report

Report Metric Details
Report Name Neuroprotection - Market
Forecasted market size in 2029 US$ 32780 million
CAGR 4.5%
Forecasted years 2023 - 2029
Global Neuroprotection market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neuroprotection market, Segment by Type:
  • Free Anti-Inflammatory Agents
  • Radical Trapping Agents (Antioxidants)
  • Apoptosis Inhibitors
  • Glutamate Antagonists (Anti-Excitotoxic Agents)
  • Neurotrophic Factors (NTFs)
  • Stimulants
  • Metal Ion Chelators
  • Others
Global Neuroprotection market, by Application
  • Prevention
  • Treatment
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Neuroprotection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Neuroprotection - Market size in 2029?

Ans: The Neuroprotection - Market size in 2029 will be US$ 32780 million.

What are the Application segmentation covered in the Neuroprotection - Market report?

Ans: The Applications covered in the Neuroprotection - Market report are Prevention, Treatment

What are the Type segmentation covered in the Neuroprotection - Market report?

Ans: The Types covered in the Neuroprotection - Market report are Free Anti-Inflammatory Agents, Radical Trapping Agents (Antioxidants), Apoptosis Inhibitors, Glutamate Antagonists (Anti-Excitotoxic Agents), Neurotrophic Factors (NTFs), Stimulants, Metal Ion Chelators, Others

1 Market Overview of Neuroprotection
1.1 Neuroprotection Market Overview
1.1.1 Neuroprotection Product Scope
1.1.2 Neuroprotection Market Status and Outlook
1.2 Global Neuroprotection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuroprotection Market Size by Region (2018-2029)
1.4 Global Neuroprotection Historic Market Size by Region (2018-2023)
1.5 Global Neuroprotection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuroprotection Market Size (2018-2029)
1.6.1 North America Neuroprotection Market Size (2018-2029)
1.6.2 Europe Neuroprotection Market Size (2018-2029)
1.6.3 Asia-Pacific Neuroprotection Market Size (2018-2029)
1.6.4 Latin America Neuroprotection Market Size (2018-2029)
1.6.5 Middle East & Africa Neuroprotection Market Size (2018-2029)
2 Neuroprotection Market by Type
2.1 Introduction
2.1.1 Free Anti-Inflammatory Agents
2.1.2 Radical Trapping Agents (Antioxidants)
2.1.3 Apoptosis Inhibitors
2.1.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
2.1.5 Neurotrophic Factors (NTFs)
2.1.6 Stimulants
2.1.7 Metal Ion Chelators
2.1.8 Others
2.2 Global Neuroprotection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuroprotection Historic Market Size by Type (2018-2023)
2.2.2 Global Neuroprotection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuroprotection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuroprotection Revenue Breakdown by Type (2018-2029)
3 Neuroprotection Market Overview by Application
3.1 Introduction
3.1.1 Prevention
3.1.2 Treatment
3.2 Global Neuroprotection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuroprotection Historic Market Size by Application (2018-2023)
3.2.2 Global Neuroprotection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuroprotection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuroprotection Revenue Breakdown by Application (2018-2029)
4 Neuroprotection Competition Analysis by Players
4.1 Global Neuroprotection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroprotection as of 2022)
4.3 Date of Key Players Enter into Neuroprotection Market
4.4 Global Top Players Neuroprotection Headquarters and Area Served
4.5 Key Players Neuroprotection Product Solution and Service
4.6 Competitive Status
4.6.1 Neuroprotection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F. Hoffmann-La Roche
5.1.1 F. Hoffmann-La Roche Profile
5.1.2 F. Hoffmann-La Roche Main Business
5.1.3 F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
5.1.4 F. Hoffmann-La Roche Neuroprotection Revenue (US$ Million) & (2018-2023)
5.1.5 F. Hoffmann-La Roche Recent Developments
5.2 Eli Lilly and Company
5.2.1 Eli Lilly and Company Profile
5.2.2 Eli Lilly and Company Main Business
5.2.3 Eli Lilly and Company Neuroprotection Products, Services and Solutions
5.2.4 Eli Lilly and Company Neuroprotection Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly and Company Recent Developments
5.3 Daiichi Sankyo Company
5.3.1 Daiichi Sankyo Company Profile
5.3.2 Daiichi Sankyo Company Main Business
5.3.3 Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
5.3.4 Daiichi Sankyo Company Neuroprotection Revenue (US$ Million) & (2018-2023)
5.3.5 Allergan Recent Developments
5.4 Allergan
5.4.1 Allergan Profile
5.4.2 Allergan Main Business
5.4.3 Allergan Neuroprotection Products, Services and Solutions
5.4.4 Allergan Neuroprotection Revenue (US$ Million) & (2018-2023)
5.4.5 Allergan Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Neuroprotection Products, Services and Solutions
5.5.4 Novartis Neuroprotection Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Neuroprotection Products, Services and Solutions
5.6.4 AstraZeneca Neuroprotection Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Dr. Reddy's Laboratories
5.7.1 Dr. Reddy's Laboratories Profile
5.7.2 Dr. Reddy's Laboratories Main Business
5.7.3 Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
5.7.4 Dr. Reddy's Laboratories Neuroprotection Revenue (US$ Million) & (2018-2023)
5.7.5 Dr. Reddy's Laboratories Recent Developments
5.8 Astrocyte Pharmaceuticals
5.8.1 Astrocyte Pharmaceuticals Profile
5.8.2 Astrocyte Pharmaceuticals Main Business
5.8.3 Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
5.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue (US$ Million) & (2018-2023)
5.8.5 Astrocyte Pharmaceuticals Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Neuroprotection Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
5.10 Biogen
5.10.1 Biogen Profile
5.10.2 Biogen Main Business
5.10.3 Biogen Neuroprotection Products, Services and Solutions
5.10.4 Biogen Neuroprotection Revenue (US$ Million) & (2018-2023)
5.10.5 Biogen Recent Developments
6 North America
6.1 North America Neuroprotection Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neuroprotection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuroprotection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuroprotection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuroprotection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuroprotection Market Dynamics
11.1 Neuroprotection Industry Trends
11.2 Neuroprotection Market Drivers
11.3 Neuroprotection Market Challenges
11.4 Neuroprotection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Neuroprotection Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Neuroprotection Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Neuroprotection Market Size Share by Region (2018-2023)
    Table 4. Global Neuroprotection Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Neuroprotection Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Neuroprotection Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Neuroprotection Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Neuroprotection Revenue Market Share by Type (2018-2023)
    Table 9. Global Neuroprotection Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Neuroprotection Revenue Market Share by Type (2024-2029)
    Table 11. North America Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Neuroprotection Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Neuroprotection Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Neuroprotection Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Neuroprotection Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Neuroprotection Revenue Market Share by Application (2018-2023)
    Table 24. Global Neuroprotection Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Neuroprotection Revenue Market Share by Application (2024-2029)
    Table 26. North America Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Neuroprotection Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Neuroprotection Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Neuroprotection Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Neuroprotection Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuroprotection as of 2022)
    Table 39. Date of Key Players Enter into Neuroprotection Market
    Table 40. Global Neuroprotection Key Players Headquarters and Area Served
    Table 41. Neuroprotection Product Solution and Service
    Table 42. Global Neuroprotection Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. F. Hoffmann-La Roche Basic Information List
    Table 45. F. Hoffmann-La Roche Description and Business Overview
    Table 46. F. Hoffmann-La Roche Neuroprotection Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Neuroprotection Business of F. Hoffmann-La Roche (2018-2023)
    Table 48. F. Hoffmann-La Roche Recent Developments
    Table 49. Eli Lilly and Company Basic Information List
    Table 50. Eli Lilly and Company Description and Business Overview
    Table 51. Eli Lilly and Company Neuroprotection Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Neuroprotection Business of Eli Lilly and Company (2018-2023)
    Table 53. Eli Lilly and Company Recent Developments
    Table 54. Daiichi Sankyo Company Basic Information List
    Table 55. Daiichi Sankyo Company Description and Business Overview
    Table 56. Daiichi Sankyo Company Neuroprotection Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Neuroprotection Business of Daiichi Sankyo Company (2018-2023)
    Table 58. Daiichi Sankyo Company Recent Developments
    Table 59. Allergan Basic Information List
    Table 60. Allergan Description and Business Overview
    Table 61. Allergan Neuroprotection Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Neuroprotection Business of Allergan (2018-2023)
    Table 63. Allergan Recent Developments
    Table 64. Novartis Basic Information List
    Table 65. Novartis Description and Business Overview
    Table 66. Novartis Neuroprotection Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Neuroprotection Business of Novartis (2018-2023)
    Table 68. Novartis Recent Developments
    Table 69. AstraZeneca Basic Information List
    Table 70. AstraZeneca Description and Business Overview
    Table 71. AstraZeneca Neuroprotection Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Neuroprotection Business of AstraZeneca (2018-2023)
    Table 73. AstraZeneca Recent Developments
    Table 74. Dr. Reddy's Laboratories Basic Information List
    Table 75. Dr. Reddy's Laboratories Description and Business Overview
    Table 76. Dr. Reddy's Laboratories Neuroprotection Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Neuroprotection Business of Dr. Reddy's Laboratories (2018-2023)
    Table 78. Dr. Reddy's Laboratories Recent Developments
    Table 79. Astrocyte Pharmaceuticals Basic Information List
    Table 80. Astrocyte Pharmaceuticals Description and Business Overview
    Table 81. Astrocyte Pharmaceuticals Neuroprotection Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Neuroprotection Business of Astrocyte Pharmaceuticals (2018-2023)
    Table 83. Astrocyte Pharmaceuticals Recent Developments
    Table 84. Teva Pharmaceutical Industries Basic Information List
    Table 85. Teva Pharmaceutical Industries Description and Business Overview
    Table 86. Teva Pharmaceutical Industries Neuroprotection Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Neuroprotection Business of Teva Pharmaceutical Industries (2018-2023)
    Table 88. Teva Pharmaceutical Industries Recent Developments
    Table 89. Biogen Basic Information List
    Table 90. Biogen Description and Business Overview
    Table 91. Biogen Neuroprotection Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Neuroprotection Business of Biogen (2018-2023)
    Table 93. Biogen Recent Developments
    Table 94. North America Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
    Table 95. North America Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
    Table 96. Europe Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
    Table 97. Europe Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
    Table 98. Asia-Pacific Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 99. Asia-Pacific Neuroprotection Market Size by Region (2018-2023) & (US$ Million)
    Table 100. Asia-Pacific Neuroprotection Market Size by Region (2024-2029) & (US$ Million)
    Table 101. Asia-Pacific Neuroprotection Market Share by Region (2018-2023)
    Table 102. Asia-Pacific Neuroprotection Market Share by Region (2024-2029)
    Table 103. Latin America Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Latin America Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
    Table 105. Latin America Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
    Table 106. Middle East & Africa Neuroprotection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 107. Middle East & Africa Neuroprotection Market Size by Country (2018-2023) & (US$ Million)
    Table 108. Middle East & Africa Neuroprotection Market Size by Country (2024-2029) & (US$ Million)
    Table 109. Neuroprotection Market Trends
    Table 110. Neuroprotection Market Drivers
    Table 111. Neuroprotection Market Challenges
    Table 112. Neuroprotection Market Restraints
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuroprotection Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Neuroprotection Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Neuroprotection Market Share by Regions: 2022 VS 2029
    Figure 4. Global Neuroprotection Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Neuroprotection Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Free Anti-Inflammatory Agents
    Figure 11. Global Free Anti-Inflammatory Agents Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Radical Trapping Agents (Antioxidants)
    Figure 13. Global Radical Trapping Agents (Antioxidants) Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Apoptosis Inhibitors
    Figure 15. Global Apoptosis Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Glutamate Antagonists (Anti-Excitotoxic Agents)
    Figure 17. Global Glutamate Antagonists (Anti-Excitotoxic Agents) Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Product Picture of Neurotrophic Factors (NTFs)
    Figure 19. Global Neurotrophic Factors (NTFs) Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 20. Product Picture of Stimulants
    Figure 21. Global Stimulants Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Product Picture of Metal Ion Chelators
    Figure 23. Global Metal Ion Chelators Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Product Picture of Others
    Figure 25. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Global Neuroprotection Market Size Share by Type: 2022 & 2029
    Figure 27. North America Neuroprotection Revenue Market Share by Type (2018-2029)
    Figure 28. Europe Neuroprotection Revenue Market Share by Type (2018-2029)
    Figure 29. Asia-Pacific Neuroprotection Revenue Market Share by Type (2018-2029)
    Figure 30. Latin America Neuroprotection Revenue Market Share by Type (2018-2029)
    Figure 31. Middle East and Africa Neuroprotection Revenue Market Share by Type (2018-2029)
    Figure 32. Prevention Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 33. Treatment Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 34. Global Neuroprotection Market Size Share by Application: 2022 & 2029
    Figure 35. North America Neuroprotection Revenue Market Share by Application (2018-2029)
    Figure 36. Europe Neuroprotection Revenue Market Share by Application (2018-2029)
    Figure 37. Asia-Pacific Neuroprotection Revenue Market Share by Application (2018-2029)
    Figure 38. Latin America Neuroprotection Revenue Market Share by Application (2018-2029)
    Figure 39. Middle East and Africa Neuroprotection Revenue Market Share by Application (2018-2029)
    Figure 40. Neuroprotection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 41. Global Top 5 and Top 10 Players Neuroprotection Market Share in 2022
    Figure 42. North America Neuroprotection Market Share by Country (2018-2029)
    Figure 43. U.S. Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 44. Canada Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 45. Germany Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 46. France Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 47. U.K. Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 48. Italy Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 49. Russia Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 50. Nordic Countries Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 51. Asia-Pacific Neuroprotection Market Share by Region (2018-2029)
    Figure 52. China Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 53. Japan Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 54. South Korea Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 55. Southeast Asia Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 56. India Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 57. Australia Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 58. Latin America Neuroprotection Market Share by Country (2018-2029)
    Figure 59. Mexico Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 60. Brazil Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 61. Middle East & Africa Neuroprotection Market Share by Country (2018-2029)
    Figure 62. Turkey Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 63. Saudi Arabia Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 64. UAE Neuroprotection Market Size (2018-2029) & (US$ Million)
    Figure 65. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS